| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2009;40:S67.)
© 2009 American Heart Association, Inc.
Prevention 1: Genetics |
From the Department of Developmental Biology (R.B.R.), Harvard School of Dental Medicine, Boston, Mass; the Childrens Hospital Informatics Program (B.E.H., M.F.R.), Harvard-MIT Division of Health Sciences and Technology, Boston, Mass; the Department of Medicine (M.M.S.), University of Virginia, Charlottesville, Va; the Department of Neurology (K.L.F.), Massachusetts General Hospital, Harvard Medical School, Boston, Mass; and the Harvard-Partners Center for Genetics and Genomics (M.F.R.), Harvard Medical School, Boston, Mass.
Correspondence to Marco F. Ramoni, PhD, Harvard-Partners Center for Genetics and Genomics, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115. E-mail marco_ramoni{at}harvard.edu
Cardioembolic stroke is a complex disease resulting from the interaction of numerous factors. Using data from Genes Affecting Stroke Risk and Outcome Study (GASROS), we show that a multivariate predictive model built using Bayesian networks is able to achieve a predictive accuracy of 86% on the fitted values as computed by the area under the receiver operating characteristic curve relative to that of the individual single nucleotide polymorphism with the highest prognostic performance (area under the receiver operating characteristic curve=60%).
Key Words: Bayesian networks genetics ischemic stroke prediction risk factors
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |